Navegar por autor "Senin Estor, Clara"

Mostrando ítems 1-7 de 7

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

2013- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]
Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

2011- Lazaro Quintela, Martín; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; Senin Estor, Clara; [et al.]
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

2014- Senin Estor, Clara
PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential

2014- Senin Estor, Clara
Revisión acerca de la eficacia y tolerabilidad del fentanilo intranasal en pectina para tratar el dolor irruptivo

2012- Senin Estor, Clara
Self-examination and risk groups in screening breast cancer

2013- Senin Estor, Clara; Castellanos Diez, Javier; Fernández Pérez, Isaura; García Cid, Noelia; Alonso Herrero, Ana [et al.]
Tolerance and efficacy of pemetrexed-cisplatin for advanced non-squamous nonsmall cell lung cancer a galician lung cancer group study

2011- Lazaro Quintela, Martín; Varela Ferreiro, Silvia; Campos Balea, Begoña; Barón Duarte, Francisco Javier; Senin Estor, Clara; [et al.]